文献速递遗传性与小管间质肾病水电解质与酸碱

HNF1β转录激活钾通道Kir5.1缺失驱动常染色体显性小管间质性肾病

Loss of transcriptional activation of the potassium channel Kir5.1 by HNF1β drives autosomal dominant tubulointerstitial kidney disease.
PubMed 文献 · Kidney Int · 2017-05-31

本研究通过ChIP-seq在mpkDCT细胞中鉴定HNF1β结合位点,发现HNF1β直接转录激活Kcnj16(编码Kir5.1),患者突变体p.Lys156Glu丧失该激活能力,敲低或敲除HNF1β均下调Kcnj16/Kcnj10表达,提示HNF1β突变致Kir5.1活性降低是低钾血症和低镁血症的机制。

要点

  • HNF1β是Kcnj16的直接转录激活因子,调控钾通道Kir5.1表达。
  • HNF1β突变体p.Lys156Glu不能激活Kcnj16表达。
  • HNF1β缺失下调Kcnj16、Kcnj10及Slc12a3转录水平。

核心结论

  • HNF1β通过转录激活Kcnj16调控Kir5.1,其突变导致Kir5.1活性降低,可能是ADTKD患者低钾血症和低镁血症的原因。

研究设计与样本

  • 在永生化小鼠肾细胞系mpkDCT中进行ChIP-seq全基因组鉴定HNF1β结合位点,共鉴定7,421个结合位点。
  • 采用荧光素酶启动子试验、突变体表达、敲低实验及HNF1β肾脏敲除小鼠模型验证。

主要发现

  • Kcnj16启动子区含高度保守且特异的HNF1β结合位点,HNF1β存在时Kcnj16表达增加2.2倍。
  • HNF1β p.Lys156Glu突变体不能激活Kcnj16表达。
  • mpkDCT细胞中敲低Hnf1β使Kcnj16(Kir5.1)和Kcnj10(Kir4.1)表达分别显著降低38%和37%。
  • HNF1β肾脏敲除小鼠较野生型肾脏中Kcnj16、Kcnj10和Slc12a3转录本分别下调78%、83%和76%。

临床怎么用

  • 对HNF1β突变相关ADTKD患者,应关注低钾血症和低镁血症,其机制可能与Kir5.1活性降低有关。

局限性

  • 研究主要基于细胞系和鼠标模型,尚未在患者肾脏组织中直接验证Kir5.1活性降低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatocyte nuclear factor 1 homeobox B (HNF1β) is an essential transcription factor for the development and functioning of the kidney. Mutations in HNF1β cause autosomal dominant tubulointerstitial kidney disease characterized by renal cysts and maturity-onset diabetes of the young (MODY). Moreover, these patients suffer from a severe electrolyte phenotype consisting of hypomagnesemia and hypokalemia. Until now, genes that are regulated by HNF1β are only partially known and do not fully explain the phenotype of the patients. Therefore, we performed chIP-seq in the immortalized mouse kidney cell line mpkDCT to identify HNF1β binding sites on a genome-wide scale. In total 7,421 HNF1β-binding sites were identified, including several genes involved in electrolyte transport and diabetes. A highly specific and conserved HNF1β site was identified in the promoter of Kcnj16 that encodes the potassium channel Kir5.1. Luciferase-promoter assays showed a 2.2-fold increase in Kcnj16 expression when HNF1β was present. Expression of the Hnf1β p.Lys156Glu mutant, previously identified in a patient with autosomal dominant tubulointerstitial kidney disease, did not activate Kcnj16 expression. Knockdown of Hnf1β in mpkDCT cells significantly reduced the appearance of Kcnj16 (Kir5.1) and Kcnj10 (Kir4.1) by 38% and 37%, respectively. These results were confirmed in a HNF1β renal knockout mouse which exhibited downregulation of Kcnj16, Kcnj10 and Slc12a3 transcripts in the kidney by 78%, 83% and 76%, respectively, compared to HNF1β wild-type mice. Thus, HNF1β is a transcriptional activator of Kcnj16. Hence, patients with HNF1β mutations may have reduced Kir5.1 activity in the kidney, resulting in hypokalemia and hypomagnesemia.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Kompatscher A, de Baaij JHF, Aboudehen K, et al. Loss of transcriptional activation of the potassium channel Kir5.1 by HNF1β drives autosomal dominant tubulointerstitial kidney disease. Kidney Int. 2017. PMID: 28577853. doi:10.1016/j.kint.2017.03.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。